Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability

References

• Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett, 94:79–83.
   PubMed Web of Science ®Google Scholar
• Srimal RC, Dhawan BN. (1973). Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inammatory agent. J Pharm Pharmacol, 25:447–52.
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Kawakishi S, Osawa T. (1996). Involvement of the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol, 52:519–25.
   PubMed Web of Science ®Google Scholar
• Kim MK, Choi GJ, Lee HS. (2003). Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse. J Agric Food Chem, 51:1578–81.
   PubMed Web of Science ®Google Scholar
• Mahady GB, Pendland SL, Yun G, Lu ZZ. (2002). Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res, 22:4179–81.
   PubMed Web of Science ®Google Scholar
• Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. (2005). Curcumin for malaria therapy. Biochem Biophys Res Commun, 326:472–4.
   PubMed Web of Science ®Google Scholar
• Qureshi S, Shah AH, Ageel AM. (1992). Toxicity studies on Alpinia galanga and Curcuma longa. Planta Med, 58:124–7.
   PubMed Web of Science ®Google Scholar
• Shankar TN, Shantha NV, Ramesh HP, Murthy IA, Murthy VS. (1980). Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guineapigs & monkeys. Indian J Exp Biol, 18:73–5.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, . (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res, 21(4B):2895–900.
   PubMed Web of Science ®Google Scholar
• Lao CD, Demierre MF, Sondak VK. (2006). Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert Rev Anticancer Ther, 6:1559–68.
   PubMed Web of Science ®Google Scholar
• Lao CD, Rufn MT, Normolle D, Heath DD, Murray SI, Bailey JM, . (2006). Dose escalation of a curcuminoid formulation. BMC Complement Altern Med, 6:10–7.
   PubMedGoogle Scholar
• Aggarwal BB, Sundaram C, Malani N, Ichikawa H. (2007). Curcumin: The Indian solid gold. Adv Exp Med Biol, 595:1–75.
   PubMed Web of Science ®Google Scholar
• Anant P, Anshuman AA, Bhimrao KJ, Mahadik KR. (2004). Characterization of curcumin–PVP solid dispersion obtained by spray drying. Int J Pharm, 271:281–6.
   PubMed Web of Science ®Google Scholar
• Ansari MJ, Ahmad S, Kohli K, Ali J, Khar RK. (2005). Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations. J Pharm Biomed Anal, 39:132–8.
   PubMed Web of Science ®Google Scholar
• Ravindranath V, Chandrasekhara N. (1980). Absorption and tissue distribution of curcumin in rats. Toxicology, 16:259–65.
   PubMed Web of Science ®Google Scholar
• Cui SM, Zhao CS, Chen DW, He ZG. (2005). Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone. Drug Dev Ind Pharm, 31:349–56.
   PubMed Web of Science ®Google Scholar
• Attivi D, Ajana I, Astier A, Demoré B, Gibaud S. (2010). Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm, 36:421–7.
   PubMed Web of Science ®Google Scholar
• Patel D, Sawant KK. (2007). Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm, 33:1318–26.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun P, Nie S, Pan W. (2005). Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm, 31:785–94.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev, 45:89–121.
   PubMed Web of Science ®Google Scholar
• Paul BK, Moulik SP. (1997). Microemulsions: An overview. J Dispers Sci Technol, 8:301–67.
   Web of Science ®Google Scholar
• Teichmann A, Heuschkel S, Jacobi U, Presse G, Neubert RH, Sterry W, . (2007). Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm, 67:699–706.
   PubMed Web of Science ®Google Scholar
• Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, . (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm, 371:148–55.
   PubMed Web of Science ®Google Scholar
• Xu HL, Sun Y, Shao JZ, Xiong LR, Zhang N, Huang CG. (2007). Study on pharmacokinetics of the curcumin liposomes in rat. J Hubei Coll Tradit Chin Med, 9:42–5.
   Google Scholar
• Chen Y, Li G, Wu XG, Chen ZY, Hang JG, Qin B, . (2008). Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: Formulation development and in vivo assessment. Biol Pharm Bull, 31:118–25.
   PubMed Web of Science ®Google Scholar
• Pharmacopoeia of the People's Republic of China. II [S]. (2005). Appendix 73.
   Google Scholar
• Pouton CW. (1985). Self-emulsifying drug delivery systems: Assessment of the efficiency of emulsification. Int J Pharm, 27:335–48.
   Web of Science ®Google Scholar
• Borhade VB, Nair HA, Hegde DD. (2009). Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration. Drug Dev Ind Pharm, 35:619–30.
   PubMed Web of Science ®Google Scholar
• Constantinides PP. (1995). Lipid microemulsion for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res, 12:1561–72.
   PubMed Web of Science ®Google Scholar
• Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm, 35:603–11.
   PubMed Web of Science ®Google Scholar
• Meng J, Zheng LY. (2007). Application of mixture experimental design to simvastatin apparent solubility predictions in the microemulsifion formed by self-microemulsifying. Drug Dev Ind Pharm, 33:927–31.
   PubMed Web of Science ®Google Scholar
• Eccleston GM. (1992). Microemulsions. In: Swarbrick S, Boylan JC, eds. Encyclopedia of pharmaceutical technology. New York: Marcel Dekker, Inc., 375–421.
   Google Scholar
• Pouton CW. (1985). Effects of inclusion of a model drug on the performance of self-emulsifying formulations. J Pharm Pharmacol, 37:1–11.
   PubMed Web of Science ®Google Scholar
• Gershanik T, Benita S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179–88.
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, . (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 274:65–73.
   PubMed Web of Science ®Google Scholar
• O'Driscoll CM. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci, 15:405–15.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Li XR, Wang HJ, Li XY, Liu Y. (2004). The absorption kinetics of silymarin microemulsion in rat intestine. Acta Pharmacol Sin, 39:631–4.
   Google Scholar
• Swenson ES, Milisen WB, Curatolo W. (1994). Intestinal permeability enhancement: Efficacy, acute local toxicity and reversibility. Pharm Res, 11:1132–42.
   PubMed Web of Science ®Google Scholar
• Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother, 58:173–82.
   PubMed Web of Science ®Google Scholar
• Wahlstrom B, Blennow G. (1978). A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh), 43:86–92.
   PubMedGoogle Scholar
• Pan MH, Huang TM, Lin JK. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos, 27:486–94.
   PubMed Web of Science ®Google Scholar
• Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med, 64:353–6.
   PubMed Web of Science ®Google Scholar
• Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. (1994). Self-emulsifying drug delivery system (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm, 106:15–23.
   Web of Science ®Google Scholar
• Sha XY, Yan GJ, Wu YJ, Li JC, Fang XL. (2005). Effect of self‐microemulsifying drug delivery systems containing labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci, 24:477–86.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter CJ. (2008). Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update. Adv Drug Deliv Rev, 60:702–16.
   PubMed Web of Science ®Google Scholar
• Woo JS, Lee CH, Shim CK, Hwang SC. (2003). Enhanced oral bioavailability of paclitaxel by co-administration of the P-glycoprotein inhibitor KR30031. Pharm Res, 20:24–30.
   PubMed Web of Science ®Google Scholar